Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL
In: Cancer Science, Jg. 114 (2023), Heft 6, S. 2689-2691
academicJournal
Zugriff:
Titel: |
Five‐year follow‐up of a phase II study of DA‐EPOCH‐R with high‐dose MTX in CD5‐positive DLBCL
|
---|---|
Autor/in / Beteiligte Person: | Miyazaki, Kana ; Sakai, Rika ; Iwaki, Noriko ; Yamamoto, Go ; Murayama, Kayoko ; Nishikori, Momoko ; Sunami, Kazutaka ; Yoshida, Isao ; Yano, Hiroki ; Takahashi, Naoki ; Okamoto, Akinao ; Munemoto, Saori ; Sawazaki, Aiko ; Suehiro, Youko ; Fukuhara, Noriko ; Wake, Atsushi ; Arai, Ayako ; Masaki, Yasufumi ; Toyama, Kohtaro ; Yokoyama, Akihiro ; Tsunemine, Hiroko ; Hasegawa, Yuichi ; Matsumoto, Kenji ; Yamada, Tomomi ; Nishimura, Yuki ; Tamaru, Satoshi ; Asano, Naoko ; Miyawaki, Kohta ; Izutsu, Koji ; Kinoshita, Tomohiro ; Suzuki, Ritsuro ; Ohshima, Koichi ; Kato, Koji ; Katayama, Naoyuki ; Yamaguchi, Motoko ; Japan Agency for Medical Research and Development |
Link: | |
Zeitschrift: | Cancer Science, Jg. 114 (2023), Heft 6, S. 2689-2691 |
Veröffentlichung: | Wiley, 2023 |
Medientyp: | academicJournal |
ISSN: | 1347-9032 |
DOI: | 10.1111/cas.15784 |
Schlagwort: |
|
Sonstiges: |
|